Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
about
Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centersBotulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.OnabotulinumtoxinA injections in chronic migraine, targeted to sites of pericranial myofascial pain: an observational, open label, real-life cohort study.Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations.Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy.
P2860
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
@en
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine.
@nl
type
label
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
@en
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine.
@nl
prefLabel
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
@en
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine.
@nl
P2093
P2860
P1476
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
@en
P2093
Andreas A Argyriou
Dimos D Mitsikostas
Emmanouil V Dermitzakis
Konstantinos C Spingos
P2860
P2888
P356
10.1186/S10194-016-0676-Z
P577
2016-09-17T00:00:00Z
P6179
1032824453